Steven Cordio

Steven Cordio currently serves as the Head of Financial Planning and Analysis for the Peptide Division at Biosynth since February 2024. Previously, Steven held various finance leadership roles, including Business Unit Finance Director at IPL and Finance and Accounting Consultant at Supernus Pharmaceuticals, Inc. Between July 2017 and January 2022, Steven was the Senior Director of FP&A and Controlling for the Americas Region at Fresenius Medical Care North America. Prior experience includes serving as Global Operations Controller at A. W. Chesterton Company and Operations Controller at SeraCare Life Sciences. Steven's career began at Georgia-Pacific LLC, where responsibilities included Manufacturing Controller and Division FP&A Lead. Educational qualifications include an MBA in Business Management from Washburn University and a BSBA in Accounting from Fitchburg State University.